Deferred Income Tax Liabilities, Net of Merck & Co., Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Merck & Co., Inc. quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Merck & Co., Inc. Deferred Income Tax Liabilities, Net for the quarter ending 31 Dec 2025 was $1,439,000,000, a 3.7% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

Merck & Co., Inc. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,439,000,000 +$52,000,000 +3.7% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $1,381,000,000 +$517,000,000 +60% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,427,000,000 +$551,000,000 +63% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $1,409,000,000 +$487,000,000 +53% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $1,387,000,000 +$516,000,000 +59% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $864,000,000 -$154,000,000 -15% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $876,000,000 -$120,000,000 -12% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $922,000,000 -$520,000,000 -36% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $871,000,000 -$924,000,000 -51% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $1,018,000,000 -$1,399,000,000 -58% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $996,000,000 -$1,978,000,000 -67% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $1,442,000,000 -$1,629,000,000 -53% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $1,795,000,000 -$1,646,000,000 -48% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $2,417,000,000 +$890,000,000 +58% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $2,974,000,000 +$1,485,000,000 +100% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $3,071,000,000 +$1,867,000,000 +155% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $3,441,000,000 +$2,436,000,000 +242% 31 Dec 2021 10-K 24 Feb 2023 2022 FY
Q3 2021 $1,527,000,000 -$250,000,000 -14% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $1,489,000,000 -$602,000,000 -29% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $1,204,000,000 -$739,000,000 -38% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $1,005,000,000 -$465,000,000 -32% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $1,777,000,000 -$183,000,000 -9.3% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $2,091,000,000 +$2,000,000 +0.1% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $1,943,000,000 +$108,000,000 +5.9% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $1,470,000,000 -$232,000,000 -14% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $1,960,000,000 -$105,000,000 -5.1% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $2,089,000,000 -$70,000,000 -3.2% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $1,835,000,000 -$371,000,000 -17% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $1,702,000,000 -$517,000,000 -23% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 $2,065,000,000 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 $2,159,000,000 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $2,206,000,000 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 $2,219,000,000 -$2,858,000,000 -56% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q4 2016 $5,077,000,000 31 Dec 2016 10-K 27 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.